Policy | June 25, 2026
Experts call for uniform quality standards for blood and blood components
National conference brings together 160+ experts from six states to advance blood quality and safety standards
National conference brings together 160+ experts from six states to advance blood quality and safety standards
Initiative conducted in association with IMA Charitable Blood Centre promotes voluntary blood donation and community awareness on life-saving transfusions
Exclusive partnership introduces globally benchmarked stem cell processing platform aimed at improving stem cell recovery, quality, and long-term therapeutic potential
The company will present 21 oral and poster presentations spanning investigational and approved therapies
BPDCN typically presents with skin lesions before rapidly spreading to the bone marrow, lymph nodes
The test is designed to help clinicians either rule in or rule out amyloid pathology in patients showing signs of cognitive decline
The move puts a spotlight on one of psychiatry’s most persistent clinical challenges: misdiagnosis and delay
Patients receiving ELREXFIO largely remained free from disease progression during the interim analysis
Ajax's lead program, AJ1-11095, is a first-in-class Type II JAK2 inhibitor currently in Phase 1 clinical development, with first proof-of-concept clinical data to be presented later in 2026
The company has supported the initiative since its inception, contributing to screening efforts in around 120 countries
Subscribe To Our Newsletter & Stay Updated
